Literature DB >> 3745874

Anthelmintic activity of triclabendazole.

G C Coles.   

Abstract

Triclabendazole was tested in vitro and in vivo against a range of helminths. Although in vitro activity was found against Hymenolepis diminuta (0.5 microgram/ml), Fasciola hepatica (2.5 micrograms/ml), Taenia crassiceps and Schistosoma mansoni (50 micrograms/ml), in vivo activity was only found against F. hepatica, a single oral dose of 40 mg/kg killing 99% of adult flukes in the rat. This spectrum of activity suggests a mechanism of action unlike that of other benzimidazole anthelmintics.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3745874     DOI: 10.1017/s0022149x00026110

Source DB:  PubMed          Journal:  J Helminthol        ISSN: 0022-149X            Impact factor:   2.170


  9 in total

1.  A new report of triclabendazole efficacy during invading phase fasciolasis.

Authors:  S Picot; M Querrec; J L Ghez; A Goullier-Fleuret; R Grillot; P Ambroise-Thomas
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-03       Impact factor: 3.267

2.  Evaluation of activity of triclabendazole against Taenia solium metacestode in naturally infected pigs.

Authors:  Ana Vargas-Calla; Luis A Gomez-Puerta; Juan Calcina; Omar Gonzales-Viera; Cesar Gavidia; Maria T Lopez-Urbina; Hector H Garcia; Armando E Gonzalez
Journal:  Asian Pac J Trop Med       Date:  2015-12-19       Impact factor: 1.226

3.  Response of two isolates of Fasciola hepatica to treatment with triclabendazole in vivo and in vitro.

Authors:  S M Walker; B McKinstry; J C Boray; G P Brennan; A Trudgett; E M Hoey; H Fletcher; I Fairweather
Journal:  Parasitol Res       Date:  2004-10-28       Impact factor: 2.289

4.  Effect of a novel benzimidazole derivative in experimental Schistosoma mansoni infection.

Authors:  Serry A El Bialy; Amira Taman; Samar N El-Beshbishi; Basem Mansour; Mohamed El-Malky; Waleed A Bayoumi; Hassan M Essa
Journal:  Parasitol Res       Date:  2013-10-06       Impact factor: 2.289

5.  Fasciola hepatica: tegumental surface changes in adult and juvenile flukes following treatment in vitro with the sulphoxide metabolite of triclabendazole (Fasinex).

Authors:  A W Stitt; I Fairweather
Journal:  Parasitol Res       Date:  1993       Impact factor: 2.289

6.  Comprehensive analysis of the catalytic and structural properties of a mu-class glutathione s-transferase from Fasciola gigantica.

Authors:  Jupitara Kalita; Rohit Shukla; Harish Shukla; Kundlik Gadhave; Rajanish Giri; Timir Tripathi
Journal:  Sci Rep       Date:  2017-12-13       Impact factor: 4.379

7.  Draft Genome of the Liver Fluke Fasciola gigantica.

Authors:  Tripti Pandey; Arpita Ghosh; Vivek N Todur; Vijayakumar Rajendran; Parismita Kalita; Jupitara Kalita; Rohit Shukla; Purna B Chetri; Harish Shukla; Amit Sonkar; Denzelle Lee Lyngdoh; Radhika Singh; Heena Khan; Joplin Nongkhlaw; Kanhu Charan Das; Timir Tripathi
Journal:  ACS Omega       Date:  2020-05-06

8.  Identification and characterization of cytosolic malate dehydrogenase from the liver fluke Fasciola gigantica.

Authors:  Purna Bahadur Chetri; Rohit Shukla; Timir Tripathi
Journal:  Sci Rep       Date:  2020-08-07       Impact factor: 4.379

Review 9.  Recent advancements in the control of Taenia solium: A systematic review.

Authors:  T de Coster; I Van Damme; J Baauw; S Gabriël
Journal:  Food Waterborne Parasitol       Date:  2018-11-13
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.